Eli Lilly to Acquire Adverum Biotechnologies for Up to $12.47 a Share

Published 2 weeks ago • Oct 24, 2025 at 12:56 PM • Positive

Eli Lilly (LLY) has agreed to acquire Adverum Biotechnologies (ADVM) including its lead product cand

PREMIUM

Upgrade to read this MT Newswires article and get so much more.

A Silver or Gold subscription plan is required to access premium news articles.

Upgrade

Already have a subscription? Sign in

Menu

Eli Lilly to Acquire Adverum Biotechnologies for Up to $12.47 a Share

Related Stocks

More News

Leishen Energy(LSE) Makes a Strong Debut at ADIPEC Abu Dhabi, Embarking on a New Chapter of Strategic Expansion in the Middle East and International Markets

Startups from Australia, India and UAE crowned winners in L'Oréal Groupe's biggest Beauty Tech competition across South Asia Pacific, Middle East and North Africa

Kirin: Development of a Fermented Ingredient Derived from Coffee Cherries to Enhance Body and Aroma Contributing to the Sustainability of Coffee Farms, Reduction of Environmental Impact, and Addressing Alcohol-related Social Issues

ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action – CYTK

FLY Investor News: If You Have Suffered Losses in Firefly Aerospace Inc. (NASDAQ: FLY), You Are Encouraged to Contact The Rosen Law Firm About Your Rights